SUVENPHAR.BOSUVENPHAR.BOBSE
Loading
Year-over-year SG&A expense growth
Latest
0.00%
↓ 100% vs avg
Percentile
P29
Within normal range
Streak
1 qtr
Consecutive growthDecelerating
Average
5.73%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.00% |
| Q3 2025 | -100.00% |
| Q2 2025 | 39.25% |
| Q1 2025 | 51.27% |
| Q4 2024 | 22.02% |
| Q3 2024 | 13.70% |
| Q2 2024 | -7.72% |
| Q1 2024 | 50.57% |
| Q4 2023 | 14.89% |
| Q3 2023 | -0.58% |
| Q2 2023 | -22.00% |
| Q1 2023 | 24.18% |
| Q4 2022 | 3.59% |
| Q3 2022 | 7.76% |
| Q2 2022 | -19.47% |
| Q1 2022 | 32.00% |
| Q4 2021 | 7.82% |
| Q3 2021 | 9.62% |
| Q2 2021 | 13.16% |
| Q1 2021 | -12.41% |
| Q4 2020 | 2.00% |
| Q3 2020 | 19.98% |
| Q2 2020 | -19.90% |
| Q1 2020 | 41.23% |
| Q4 2019 | 1.07% |
| Q3 2019 | -10.50% |
| Q2 2019 | 4.74% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |